EPPM
EPPM-1
1st Conference of the European Platform
for Photodynamic Medicine
Hosted By: Ruđer Bošković Institute, Zagreb, Croatia
Official PCO: Rahtanea
Programme

Monday, 24th March

19.00 - 21.00 Welcome party

 

Tuesday, 25th March

8.30 - 9.00 Opening : H. Zorc (Cro), K. Moghissi (UK) and G. Jori (I)
9.00 - 9.30 I-1 W. Rauschning: Boosting the public awarness for Photodynamic Medicine
Mechanisms of action - * Chairpersons:  H. Zorc (Cro), K. Moghissi (UK) and   H. Walt (CH)
9.30 - 10.00 I-2 Yoram Salomon: Vascular-Targeted Photodynamic Therapy (VTP) of cancer: Acute blockade of tumor Blood Supply
10.00 - 10.15 O-1 Vanderlei Bagnato: Correlation between depth of necrosis and fluorescence during PDT
Coffee break
Photosenzitizers – *Chairpersons: K. Berg (N) and D. Boucher (Fr)
11.00 - 11.30 I-3 Ross Boyle: Selective Targeting of Photodynamic Sensitisers to Tumour Tissue
11.30 - 11.45 O-2 David Russell: Phthalocyanine-nanoparticle conjugates for photodynamic therapy
11.45 - 12.00 O-3 Cornelus van Nostrum: Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation
12.00 - 12.15 O-27 Muriel Barberi-Heyob: Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study
12.15 - 12.30 O-5 Mathias Senge: Synthetic Strategies for Porphyrin-based Photosensitizers
Lunch
PDD/PDT in Dermatology – *Chairpersons: J. Lipozenčić (Cro) and N. Puizina-Ivić (Cro)
14.00 - 14.30 I-4 Xiu Li Wang: Photodynamic Diagnosis and Therapy in Dermatology
14.30 - 14.45 O-6 Torello Lotti: PDT of skin HPV lesions and other viral infections
14.45 - 15.00 O-7 Dido Yova: Pharmacokinetics and Pharmacodynamics of Aluminum Phthalocyanine Chloride in a Non-Melanoma Skin Cancer Animal Model
15.00 - 15.15 O-8 Harry Moseley: Characteristics of Fluorescence induced by ALA and MAL
15.15 - 15.30 O-9 Ernest Allan: Interstitial laser fibre irradiation for PDT of thick basal cell carcinomas
15.30 - 15.45 O-10 Sasi Attili: A new light source for cutaneous PDT
Coffee break
PDD/PDT in Gastroenterology - *Chairpersons: Herwig Kostron (Au) and T. Patrice (Fr)
16.15 - 16.45 I-5 Ron Allison: Low dose Photofrin PDT improves clinical outcomes
16.45 - 17.00 O-11 Wojcijeh Latos: The role of autofluorescence colonoscopy in diagnosis and management of Solitary Rectal Ulcer Syndrome
17.00 - 17.15 O-12 Keyvan Moghissi: Comparison of endoscopic PDT with surgical resection for early oesophageal cancer
17.15 - 17.30 O-13 Sam Eljamel: PDT in metastatic brain carcinomas
 
17.30 - 18.30 GENERAL ASSEMBLY OF EPPM
 
18.30 - 20.00 Poster session         (poster dimensions: 90 cm width  x  100 cm height)
Dinner

 

Wednesday, 26th March

8.30 - 9.00 I-6 Alexis Sidoroff: PDT has come of age - time to see the world
PDD/PDT of Head and Neck – *Chairpersons: E. Vakulovskaya (Rus) and Colin Hopper (UK)
9.00 - 9.30 I-7 Bing Tan: Foscan mediated Photo Dynamic Therapy (PDT) in head and neck cancer, the Netherlands Cancer Institute Experience
9.30 - 10.00 I-8 Colin Hopper: PDT and Optical Diagnostics in the Head and Neck
10.00 - 10.15 O-14 Alexander Sieron: The role of autofluorescence diagnosis in the oral mucosa diseases
10.15 - 10.30 O-15 Libo Li: Treating laryngeal carcinoma using PHOTOFRIN photodynamic therapy
10.30 - 10.45 O-16 Max Witjes: Interstitial photodynamic therapy in recurrent head and neck carcinoma
Coffee break
PDD/PDT in Gynaecology – *Chairpersons: I. Apolikhina (Rus) and H. Walt (CH)
11.15 - 11.45 I-9 Philipp Soergel: Photodynamic Diagnosis and Therapy in Gynaecology
11.45 - 12.00 O-17 Carsten M. Philipp: PDD guided CO2-Laser Excision and PDT of AIN, VAIN and VIN
12.00 - 12.15 O-18 Olga Trushina: Photodynamic therapy (PDT) of virus-associated oncology pathology
Lunch
14.00 - 14.30 EU Health Commission presentation
Antimicrobial PDT – *Chairpersons: D. Russell (UK) and D. Provvedinni (I)
14.30 - 15.00 I-10 Giulio Jori: Applications of Photodynamic Therapy in the treatment of microbial infections
15.00 - 15.15 O-19 Nick Vasiliev: Antimicrobial photodynamic therapy: current conception of clinical applications
15.15 - 15.30 O-20 Threes Smijs: Photodynamic treatment of the dermatophyte Trichophyton rubrum with a cationic porphyrin
Coffee break
PDD/PDT in Urology and Ophthalmology
– *Chairpersons: P. Jichlinski (CH) and C. Bunce (UK)
16.00 - 16.30 I-11 Herbert Stepp: Photodynamics (PDD and PDT) for the management of bladder cancer. Development and current status
16.30 - 16.45 O-21 Zheng Huang: TOOKAD-mediated vascular-targeted photodynamic therapy (VTP) for the treatment of prostate cancer. Preclinical study
16.45 - 17.00 O-22 Johannes Swartling: Preliminary results from a clinical study of mTHPC-mediated photodynamic therapy of prostate cancer with realtime light dosimetry
17.00 - 17.15 O-23 Song Xiaodong: Photodynamic therapy for patients after transurethral resection of bladder tumor
17.15 - 17.30   H. van den Bergh: Combining PDT with anti-VEGF therapy for treating age related macular degeneration and polypoidal choroidal vasculopaty 
Break
20.00 - 23.00 Conference dinner

 

Thursday, 27th March

Pulmology and Neurosurgery –* Chairpersons: P. Barber (UK) and A. Rück (DE)
8.30 - 9.00 I-12 Keyvan Moghissi: Contribution of Photodiagnosis (autofluorescence bronchoscopy/AFB) and Photodynamic Therapy to the treatment of central type lung cancer
9.00 - 9.30 I-13 Herwig Kostron: PDT in brain cancer (the exact title will be given later)
9.30 - 9.45 O-24 Nick Vasiliev: Antimicrobial photodynamic therapy (APDT) in treatment of tuberculosis
9.45 - 10.00 O-25 Mark Stringer: Autofluorescence Bronchoscopy to detect bronchial epithelial changes associated with cigarette smoking amongst asymptomatic volunteers: A single centre prospective pilot study
Coffee break
New Developments in PDT – *Chairpersons: G. Jori (I) and B. Klem (N)
10.45 - 11.15 I-14 Mladen Korbelik: PDT-generated cancer vaccines
11.15 - 11.30 O-26 Aleksandra Kawczyk-Krupka: The influence of photodynamic therapy (PDT) with delta-aminolevulinic acid (ALA) on J-774A.1 macrophage cell line
11.30 - 11.45 O-4 Ole-Jacob Norum: Photochemical internalization (PCI) as adjuvant treatment after inadequate resection of an invasive sarcoma model
11.45 - 12.00 O-28 Angelika Rück: Cell death mechanisms of glioblastoma cells during Hypericin PDT
12.00 - 12.15 O-29 Odrun Arna Gederaas: Effects of hexyl 5-aminilevulinate and light in rat bladder cancer cells
12.15 - 12.30 O-30 Barbara Krammer: Gene expression pattern of human carcinoma cells A-431 after PDT with hypericin
Conference wrap up and closure: H. Zorc (Cro), K. Moghissi (UK) and G. Jori (I)
Lunch

* Chairpersons provisional.